A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections

CompletedOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Pneumonia, BacterialNosocomial InfectionIntraabdominal InfectionsUrinary Tract Infection
Interventions
DRUG

No intervention

This is an observational study. Doripenem will be administered as per the recommended dose, ie, 500 mg, intravenously (ie, in the vein), for every 8 hours. Duration of treatment with doripenem: for nosocomial pneumonia including ventilator-associated pneumonia patients: 7 to 14 days; for complicated intra-abdominal infection patients: 5 to 14 days; for complicated urinary tract infection, including pyelonephritis (bacterial infection of the kidneys) patients: 10 days.

Trial Locations (4)

Unknown

Cebu

Davao City

Manila

Quezon City

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutica

INDUSTRY